SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
14.83
-0.32 (-2.11%)
At close: Oct 31, 2025, 4:00 PM EDT
15.12
+0.29 (1.96%)
After-hours: Oct 31, 2025, 7:02 PM EDT
SI-BONE Revenue
SI-BONE had revenue of $48.63M in the quarter ending June 30, 2025, with 21.67% growth. This brings the company's revenue in the last twelve months to $185.26M, up 22.93% year-over-year. In the year 2024, SI-BONE had annual revenue of $167.18M with 20.37% growth.
Revenue (ttm)
$185.26M
Revenue Growth
+22.93%
P/S Ratio
3.38
Revenue / Employee
$530,837
Employees
349
Market Cap
639.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 167.18M | 28.29M | 20.37% |
| Dec 31, 2023 | 138.89M | 32.48M | 30.52% |
| Dec 31, 2022 | 106.41M | 16.26M | 18.03% |
| Dec 31, 2021 | 90.15M | 16.77M | 22.84% |
| Dec 31, 2020 | 73.39M | 6.09M | 9.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SIBN News
- 3 days ago - Impax Small Cap Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 11 days ago - SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 - GlobeNewsWire
- 7 weeks ago - SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025 - GlobeNewsWire
- 3 months ago - SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance - GlobeNewsWire
- 3 months ago - SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 - GlobeNewsWire
- 3 months ago - SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025 - GlobeNewsWire